“Efficacy and Safety of Tralokinumab in Adolescents With Moderate-to- Severe Atopic Dermatitis: Results of the Phase 3 ECZTRA 6 Trial”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 2, Mar. 2022, p. s29, https://doi.org/10.25251/skin.6.supp.s29.